Simplex Trading’s Direxion Daily S&P Biotech Bull 3X Shares LABU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,048
| Closed | -$392K | – | 3314 |
|
|
2024
Q3 | $392K | Sell |
3,048
-19,638
| -87% | -$2.53M | ﹤0.01% | 690 |
|
|
2024
Q2 | $2.57M | Buy |
+22,686
| New | +$2.57M | ﹤0.01% | 226 |
|
|
2024
Q1 | – | Sell |
-1,275
| Closed | -$155K | – | 3260 |
|
|
2023
Q4 | $155K | Sell |
1,275
-11,189
| -90% | -$1.36M | ﹤0.01% | 1043 |
|
|
2023
Q3 | $949K | Buy |
+12,464
| New | +$949K | ﹤0.01% | 357 |
|
|
2023
Q2 | – | Sell |
-1,107
| Closed | -$108K | – | 3297 |
|
|
2023
Q1 | $108K | Sell |
1,107
-234
| -17% | -$22.8K | ﹤0.01% | 979 |
|
|
2022
Q4 | $189K | Sell |
1,341
-52,945
| -98% | -$7.46M | ﹤0.01% | 812 |
|
|
2022
Q3 | $7.61M | Sell |
54,286
-6,241
| -10% | -$875K | 0.01% | 64 |
|
|
2022
Q2 | $8.16M | Buy |
60,527
+53,196
| +726% | +$7.17M | 0.01% | 68 |
|
|
2022
Q1 | $2.3M | Buy |
7,331
+3,691
| +101% | +$1.16M | ﹤0.01% | 266 |
|
|
2021
Q4 | $2.62M | Buy |
3,640
+3,183
| +696% | +$2.29M | ﹤0.01% | 251 |
|
|
2021
Q3 | $716K | Buy |
457
+97
| +27% | +$152K | ﹤0.01% | 683 |
|
|
2021
Q2 | $530K | Sell |
360
-1,445
| -80% | -$2.13M | ﹤0.01% | 828 |
|
|
2021
Q1 | $2.85M | Buy |
1,805
+1,046
| +138% | +$1.65M | 0.01% | 136 |
|
|
2020
Q4 | $1.53M | Buy |
+759
| New | +$1.53M | ﹤0.01% | 289 |
|
|
2020
Q2 | – | Sell |
-717
| Closed | -$323K | – | 2604 |
|
|
2020
Q1 | $323K | Buy |
717
+687
| +2,290% | +$309K | ﹤0.01% | 581 |
|
|
2019
Q4 | $34K | Sell |
30
-565
| -95% | -$640K | ﹤0.01% | 1343 |
|
|
2019
Q3 | $367K | Buy |
+595
| New | +$367K | ﹤0.01% | 473 |
|
|
2019
Q2 | – | Sell |
-639
| Closed | -$765K | – | 2382 |
|
|
2019
Q1 | $765K | Buy |
639
+280
| +78% | +$335K | ﹤0.01% | 291 |
|
|
2018
Q4 | $235K | Buy |
+359
| New | +$235K | ﹤0.01% | 577 |
|
|
2017
Q4 | – | Sell |
-118
| Closed | -$201K | – | 2386 |
|
|
2017
Q3 | $201K | Sell |
118
-95
| -45% | -$162K | 0.01% | 639 |
|
|
2017
Q2 | $268K | Buy |
213
+31
| +17% | +$39K | 0.01% | 559 |
|
|
2017
Q1 | $174K | Buy |
+182
| New | +$174K | 0.01% | 749 |
|